EQUITY (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Feb. 09, 2018	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Feb. 16, 2022	Jan. 03, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock Split Terms	All common stock numbers and exercise prices in this Note are reflected on a post reverse split (5 to 1) basis, which reverse split was effectuated on February 9, 2018
Options re-issued to directors		15,900,000
Exercise price			$ 0.05
Recorded option expense			$ 805,392
Risk free interest			1.37%
Dividend yield			0.00%
Volatility			142.00%
Market price			$ 0.05
Active directors options						300,000
Recorded options expense			$ 15,205
Options expected life			5 years
Number of Options repriced					900,000
Options issued		0
Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Options re-issued to directors		900,000
Officer options granted		15,000,000
Exercise price		$ 0.07
Years for options		3 years
Recorded option expense		$ 751,744
Risk free interest		1.35%
Dividend yield		0.00%
Volatility		174.00%
Market price		$ 0.07
Option expected life		3 years		3 years
Director [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Exercise price			$ 0.08
Recorded option expense				$ 38,713
Risk free interest			1.90%
Dividend yield			0.00%
Volatility			153.00%
Market price			$ 0.08
Options expected life			5 years
Term extension for directors			5 years